Association between multifocal ERG implicit time delays and adaptation in patients with diabetes

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 11, 2007, Pages 5250-5256

  Bronson Castain, Kevin W ^a   Bearse Jr , Marcus A ^a   Han, Ying ^a   Schneck, Marilyn E ^a   Barez, Shirin ^a   Adams, Anthony J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; ELECTRORETINOGRAM; ELECTRORETINOGRAPHY; HUMAN; LATENT PERIOD; PREDICTION; PRIORITY JOURNAL; RETINA; SPATIAL ORIENTATION; VISUAL ADAPTATION; WAVEFORM; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; TIME;

ADULT; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; ELECTRORETINOGRAPHY; HUMANS; MIDDLE AGED; RETINA; TIME FACTORS;

EID: 38449122533     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0180     Document Type: Article

References (40)

1. Sutter EE, Tran D. The field topography of ERG components in man, I: the photopic luminance response. Vision Res. 1992;32: 433-446.
2. Bearse MA Jr, Sutter EE. Imaging localized retinal dysfunction with the multifocal electroretinogram. J Opt Soc Am A. 1996;13:634-640.
3. Hood DC. Assessing retinal function with the multifocal technique. Prog Retin Eye Res. 2000;19:607-646.
4. Kondo M, Miyake Y, Horiguchi M, Suzuki S, Tanikawa A. Clinical evaluation of multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1995;36:2146-2150.
5. Kretschmann U, Tornow RP, Zrenner E. Multifocal ERG reveals long distance effects of a local bleach in the retina. Vision Res. 1998;38:1567-1571.
6. Kondo M, Miyake Y, Kondo N, et al. Multifocal ERG findings in complete type congenital stationary night blindness. Invest Ophthalmol Vis Sci. 2001;42:1342-1348.
7. Dolan FM, Parks S, Keating D, Dutton GN, Evans AL. Multifocal electroretinographic features of central retinal vein occlusion. Invest Ophthalmol Vis Sci. 2003;44:4954-4959.
8. Dolan FM, Parks S, Keating D, Dutton GN. Wide field multifocal and standard full field electroretinographic features of hemi retinal vein occlusion. Doc Ophthalmol. 2006;112:43-52.
9. Hvarfner C, Andreasson S, Larsson J. Multifocal electroretinography and fluorescein angiography in retinal vein occlusion. Retina. 2006;26:292-296.
10. Fortune B, Schneck ME, Adams AJ. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest Ophthalmol Vis Sci. 1999;40:2638-2651.
11. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen CH, Adams AJ. Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:948-954.
12. Han Y, Schneck ME, Bearse MA Jr, et al. Formulation and evaluation of a predictive model to identify the sites of future diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45:4106-4112.
13. Schneck ME, Bearse MA Jr, Han Y, Barez S, Jacobsen C, Adams AJ. Comparison of mfERG waveform components and implicit time measurement techniques for detecting functional change in early diabetic eye disease. Doc Ophthalmol. 2004;108:223-230.
14. Klemp K, Larsen M, Sander B, Vaag A, Brockhoff PB, Lund-Andersen H. Effect of short-term hyperglycemia on multifocal electroretinogram in diabetic patients without retinopathy. Invest Ophthalmol Vis Sci. 2004;45:3812-3819.
15. Klemp K, Sander B, Brockhoff PB, Vaag A, Lund-Andersen H, Larsen M. The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping. Invest Ophthalmol Vis Sci. 2005;46:2620-2626.
16. Bearse MA Jr, Adams AJ, Han Y, et al. A multifocal electroretinogram model predicting the development of diabetic retinopathy. Prog Retin Eye Res. 2006;25:425-448.
17. Han Y, Bearse MA Jr, Schneck ME, Barez S, Jacobsen C, Adams AJ. Towards optimal filtering of "standard" multifocal electroretinogram (mfERG) recordings: findings in normal and diabetic subjects. Br J Ophthalmol. 2004;88:543-550.
18. Greenstein VC, Holopigian K, Seiple W, Carr RE, Hood DC. Atypical multifocal ERG responses in patients with diseases affecting the photoreceptors. Vision Res. 2004;44:2867-2874.
19. Sutter EE. Imaging visual function with the multifocal m-sequence technique. Vision Res. 2001;41:1241-1255.
20. Hood DC, Greenstein V, Frishman L, et al. Identifying inner retinal contributions to the human multifocal ERG. Vision Res. 1999;39: 2285-2291.
21. Hood DC, Frishman LJ, Saszik S, Viswanathan S. Retinal origins of the primate multifocal ERG: implications for the human response. Invest Ophthalmol Vis Sci. 2002;43:1673-1685.
22. Hare WA, Ton H. Effects of APB, PDA, and TTX on ERG responses recorded using both multifocal and conventional methods in monkey: effects of APB, PDA, and TTX on monkey ERG responses. Doc Ophthalmol. 2002;105:189-222.
23. Palmowski AM, Sutter EE, Bearse MA Jr, Fung W. Mapping of retinal function in diabetic retinopathy using the multifocal electroretinogram. Invest Ophthalmol Vis Sci. 1997;38:2586-2596.
24. Kurtenbach A, Langrova H, Zrenner E. Multifocal oscillatory potentials in type 1 diabetes without retinopathy. Invest Ophthalmol Vis Sci. 2000;41:3234-3241.
25. Bearse MA Jr, Han Y, Schneck ME, Barez S, Jacobsen C, Adams AJ. Local multifocal oscillatory potential abnormalities in diabetes and early diabetic retinopathy. Invest Ophthalmol Vis Sci. 2004;45: 3259-3265.
26. Tyrberg M, Ponjavic V, Lovestam-Adrian M. Multifocal electroretinography (mfERG) in insulin dependent diabetics with and without clinically apparent retinopathy. Doc Ophthalmol. 2005;110: 137-143.
27. Hood DC, Li J. A technique for measuring individual multifocal ERG records. In: Yager D, ed. Trends in Optics and Photonics. Washington, DC: Optical Society of America; 1997:280-283.
28. Gliem H, Moller DE, Kietzmann G. The double flash ERG in diabetic retinopathy. Acta Ophthalmol (Copenh). 1973;51:85-94.
29. Barber AJ, Antonetti DA, Gardner TW. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes: the Penn State Retina Research Group. Invest Ophthalmol Vis Sci. 2000;41:3561-3568.
30. Lieth E, Barber AJ, Xu B, et al. Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy: Penn State Retina Research Group. Diabetes. 1998; 47:815-820.
31. Rungger-Brandle E, Dosso AA, Leuenberger PM. Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2000;41:1971-1980.
32. Newman EA, Frambach DA, Odette LL. Control of extracellular potassium levels by retinal glial cell K+ siphoning. Science. 1984; 225:1174-1175.
33. Kofuji P, Biedermann B, Siddharthan V, et al. Kir potassium channel subunit expression in retinal glial cells: implications for spatial potassium buffering. Glia. 2002;39:292-303.
34. Nagelhus EA, Veruki ML, Torp R, et al. Aquaporin-4 water channel protein in the rat retina and optic nerve: polarized expression in Muller cells and fibrous astrocytes. J Neurosci. 1998;18:2506-2519.
35. Brew H, Attwell D. Electrogenic glutamate uptake is a major current carrier in the membrane of axolotl retinal glial cells. Nature. 1987;327:707-709.
36. Qian H, Malchow RP, Ripps H. The effects of lowered extracellular sodium on gamma-aminobutyric acid (GABA)-induced currents of Muller (glial) cells of the skate retina. Cell Mol Neurobiol. 1993; 13:147-158.
37. Biedermann B, Bringmann A, Reichenbach A. High-affinity GABA uptake in retinal glial (Muller) cells of the guinea pig: electrophysiological characterization, immunohistochemical localization, and modeling of efficiency. Glia. 2002;39:217-228.
38. Bringmann A, Pannicke T, Grosche J, et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res. 2006;25:397-424.
39. Newman EA, Zahs KR. Modulation of neuronal activity by glial cells in the retina. J Neurosci. 1998;18:4022-4028.
40. Newman EA. Glial cell inhibition of neurons by release of ATP. J Neurosci. 2003;23:1659-1666.